Filtered by vendor Ibm
Subscriptions
Filtered by product Marketing Platform
Subscriptions
Total
13 CVE
CVE | Vendors | Products | Updated | CVSS v3.1 |
---|---|---|---|---|
CVE-2018-1920 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
IBM Marketing Platform 9.1.0, 9.1.2 and 10.1 is vulnerable to a XML External Entity Injection (XXE) attack when processing XML data. A remote attacker could exploit this vulnerability to expose sensitive information or consume memory resources. IBM X-Force ID: 152855. | ||||
CVE-2018-1424 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
IBM Marketing Platform 9.1.0, 9.1.2, and 10.1 is vulnerable to a XML External Entity Injection (XXE) attack when processing XML data. A remote attacker could exploit this vulnerability to expose sensitive information or consume memory resources. IBM X-Force ID: 139029. | ||||
CVE-2017-1107 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | 4.3 Medium |
IBM Marketing Platform 9.1.0, 9.1.2, 10.0, and 10.1 exposes sensitive information in the headers that could be used by an authenticated attacker in further attacks against the system. IBM X-Force ID: 120906. | ||||
CVE-2016-6112 | 1 Ibm | 3 Distributed Marketing, Marketing Operations, Marketing Platform | 2024-11-21 | N/A |
IBM Distributed Marketing and Marketing Platform 8.6, 9.0, 9.1, and 10.0 could allow an authenticated user to escalate their privileges and gain administrative permissions over the web application. IBM X-Force ID: 118282. | ||||
CVE-2016-0255 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
IBM Marketing Platform 9.1 and 10.0 is vulnerable to stored cross-site scripting, caused by improper validation of user-supplied input. A remote attacker could exploit this vulnerability to inject malicious script into a Web page which would be executed in a victim's Web browser within the security context of the hosting Web site, once the page is viewed. An attacker could use this vulnerability to steal the victim's cookie-based authentication credentials. IBM X-Force ID: 110564. | ||||
CVE-2016-0233 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
SQL injection vulnerability in IBM Marketing Platform 8.5.x, 8.6.x, and 9.x before 9.1.2.2 allows remote authenticated users to execute arbitrary SQL commands via unspecified vectors. | ||||
CVE-2016-0229 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
Cross-site scripting (XSS) vulnerability in IBM Marketing Platform 8.6.x and 9.x before 9.1.2.2 allows remote attackers to inject arbitrary web script or HTML via a crafted URL. | ||||
CVE-2016-0228 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
IBM Marketing Platform 10.0 could allow a remote attacker to conduct phishing attacks, caused by an open redirect vulnerability in various scripts. An attacker could exploit this vulnerability to redirect a victim to arbitrary Web sites. IBM X-Force ID: 110236. | ||||
CVE-2016-0224 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
SQL injection vulnerability in IBM Marketing Platform 8.5.x, 8.6.x, and 9.x before 9.1.2.2 allows remote attackers to execute arbitrary SQL commands via unspecified vectors. | ||||
CVE-2013-6311 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
SQL injection vulnerability in IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to execute arbitrary SQL commands via unspecified vectors. | ||||
CVE-2013-6310 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
Cross-site scripting (XSS) vulnerability in IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors. | ||||
CVE-2013-6309 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to hijack sessions, and consequently read records, modify records, or conduct transactions, via an unspecified link injection. | ||||
CVE-2013-6308 | 1 Ibm | 1 Marketing Platform | 2024-11-21 | N/A |
IBM Marketing Platform 9.1 before FP2 allows remote authenticated users to conduct phishing attacks and capture login credentials via an unspecified injection. |
Page 1 of 1.